Navigation Links
Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
Date:6/26/2008

- Data to be presented at International Shock Congress by sepsis thought

leaders -

TORONTO, June 26 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced the presentation of data that demonstrates the combined clinical effectiveness of its Endotoxin Activity Assay (EAA(TM)), the only FDA cleared diagnostic for the measurement of endotoxin, to identify patients with elevated endotoxin levels and to guide endotoxin reducing strategies, such as Toray Medical's therapeutic column, Toraymyxin(TM). The presentations will be made at a symposium entitled "Blood Purification in the Treatment of Sepsis," at the International Shock Congress in Cologne, Germany to be held from June 28-July 2.

"Several of the presentations at this important congress use data collected with Spectral's EAA(TM) and highlight the value of our product, both independently and in combination with anti-endotoxin therapies," said Dr. Paul Walker, President and CEO of Spectral. "Increasingly, EAA(TM) and Toray's therapeutic column, Toraymyxin(TM), which removes endotoxin from the bloodstream, are being recognized as a valuable combination for the diagnosis, treatment and monitoring of patients with severe sepsis."

The "Blood Purification in the Treatment of Sepsis" symposium will be held on July 1, from 8:30-10:00AM CEST. Speakers presenting data using EAA(TM) include Dr. David Klein of St. Michael's Hospital in Toronto, Canada, who will deliver a presentation entitled, "The Endotoxin Activity Assay (EAA(TM)) as a diagnostic tool for anti-endotoxin sepsis treatment". Dr. Eugen Faist of the University of Munich in Germany will speak about, "Endotoxemia and immune profiles of patients with acute sepsis due to major peritonitis". Information on the meeting, including the full scientific program, can be seen at http://www.shocksociety.org.

About Spectral Diagnosti
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. Spectral appoints Anthony Bihl to Board of Directors
6. Spectral announces 2007 financial results
7. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
8. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
9. Spectral and Toray expand collaboration to include new geographic territories
10. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ador to also Visit Detroit , ...ppia, French Ambassador for International Investme...gency, , , , ,What: Ambassador Appia is available... initiatives adopted by France to further develop ...nnovation and development., , ,When: Available for...
(Date:11/24/2009)...KJAVIK, Iceland, November 24 /PRNewswire-FirstCall...nnounced that it has received notice from,the Nasd...on stock will be,suspended as of November 30, 2009...es and Exchange Commission, which will remove deCO...he company files an appeal to the Nasdaq,Listing Q...
(Date:11/24/2009).... 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc....TO) has allowed the patent application for,its nan... NOD technology is a highly efficient approach...sive nano-particles to enable oral delivery of dru...ology is a platform technology,that can be applied...
(Date:11/24/2009)...I recently approved the Promega PowerPlex 16 HS Sy...enerating DNA records for the National DNA Index S...(PRWEB) -- The FBI recently approved the Promega ...es participating in, or generating DNA records for...ntly contains more than seven million profiles and...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...- Shown to be highly effective in strengthening bo... fractures, including spine and hip, - Reclast red...1% compared to placebo in study published in Ne...y dosing provides potential for significant compli...teoporotic fractures affect one in two women over ...
... Creating a board for a start-up tech company may ...ay appear easy just sign up the most qualified pe...directors for an early stage company should suppor...rd should become a entity that promotes, supports,...usiness. But at the very start, the only guarantee...
... MADISON, WI. - Quintessence Biosciences, Inc., a ...oducts for use in research, has finalized a three ... funding, $2.3 million, was received from individu...the Madison Development Corporation, Wisconsin Dep... investment firm. The funds raised will be allocat...
Other Biology Technology:Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 2Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 3Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 4Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 5Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 6Board Pieces 2Board Pieces 3Board Pieces 4Quintessence Secures Financing 2Quintessence Secures Financing 3
(Date:11/23/2009).... The community-associated strain of the deadly s...t to most common antibioticsposes a far greater he...s way into hospitals, according to a study in the ... , The new threat is easily picked up in fitness... increased the overall burden of MRSA within hospi...
(Date:11/23/2009)...mber 23, 2009 - The time of day matters to forest ...er produced by a research team led by Professor Ma...s vice-principal for research and colleagues in th.... George campus. , Capitalizing on their previ...the research team examined how poplar trees use th...
(Date:11/23/2009)...-- More than 160 participants gathered this week f...RES INITIATIVE conference. This year,s topic, "Syn...neers, and medical researchers to explore the engi... the emerging field of synthetic biology. , Bonn...rinceton University and this year,s conference cha...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Racial disparity studied in patients undergoing liver transplantation for hepatitis B 55586 1Racial disparity studied in patients undergoing liver transplantation for hepatitis B 55586 2Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 55583 1Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 55583 2Treating COPD Early Improves Outcomes 55579 1Treating COPD Early Improves Outcomes 55579 2Treating COPD Early Improves Outcomes 55579 3Treating COPD Early Improves Outcomes 55579 4
...hane in Earth,s atmosphere shot up in 2007, bringi...tmospheric levels of the potent greenhouse gas wer...IT researchers. , Methane levels in the atmospher...s, accounting for around one-fifth of the human co.... Until recently, the leveling off of methane leve...
...m a horror movie, the swarm of bacteria ripples pu... on. , Researchers at the University of Iowa are ...xanthus) , a bacterium commonly found in soil, whi...role in the bacterial world, M. xanthus is harml...ly to destroy harmful bacteria on surfaces or in h...
...ch team headed by School of Life Sciences Associat...han $6.3 million in awards from the National Insti...the studies will examine the ecology and evolution...c mysteries behind the host shift of retroviral di... investigator of the malarial studies, will undert...
Other Biology News:Methane gas levels begin to increase again 2Predatory bacterial swarm uses rippling motion to reach prey 2Predatory bacterial swarm uses rippling motion to reach prey 3ASU researchers receive NIH awards for studies of malaria and emergent disease 2ASU researchers receive NIH awards for studies of malaria and emergent disease 3ASU researchers receive NIH awards for studies of malaria and emergent disease 4
Mouse Anti-Human STX18 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Phosphothreonine-Proline / Phosphoserine-Proline Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, FITC Conjugated, Clone LO-MM-9 from Cell Sciences
Biology Products: